Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03650972
Other study ID # T194/2018
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 15, 2018
Est. completion date December 31, 2020

Study information

Verified date August 2018
Source Turku University Hospital
Contact Susanna Koski
Phone +358408395362
Email sskosk@utu.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall objective of this randomized controlled trial is to develop a clinical standard procedure for measuring lactate in amniotic fluid (amniotic fluid lactate = = AFL) during childbirth before oxytocin stimulation is started. The aim is to reduce the need for emergency caesarean section during dysfunctional labour. The aim is also to study how different substances (oxytocin and Samarin®) affect uterine metabolic status during labour.

Labour dystocia, i.e. prolonged labour, occurs in up to 30% in primipara deliveries and in about 20% of all the deliveries. In 2016, in Finland oxytocin stimulation was used in 42% of all the deliveries.

The uterus, myometrium, is one of the largest muscles in the human body and consists mainly of smooth muscle cells. During the contractions the myometrial vessels also contract, causing momentary hypoxia and activation of anaerobic metabolism: O2 and pH levels of the muscle cell decreases and the lactate concentration increases. After the contraction, the blood circulation is restored and the anaerobic metabolites gradually dissolve. Myometrium requires a sufficiently long break between the contractions to recover. In dysfunctional labour the anaerobic metabolites accumulate in the myometrium. Accumulation of lactate has proved significantly to reduce the spontaneous contractions of myometrium and hinder myometrium calcium metabolism, which in turn reduces the strength of the contractions. Amniotic fluid lactate is known to reflect the metabolic state of the uterus during the labour.

Prolonged labour can in many aspects be compared to the athlete's tired muscles. Many of today's athletes try to control the accumulation of lactic acid in their muscles during training by drinking baking soda (bicarbonate) dissolved in water one hour before their physical activity. Bicarbonate is known to function as a lactic acid buffer. Bicarbonate is considered as food and is sold in grocery stores as baking soda and for example as Samarin®. Samarin® is safe to use during pregnancy because as a bicarbonate it does not pass through placenta and does not affect the fetus.

The trial aims to research if high AFL values (AFL > 12 mmol/L) in women with labour arrest are best treated by:

A) treating the labour according to the hospital's current guidelines during labour arrest, i.e. starting the stimulation with oxytocin and measuring the AFL again after one hour B) administering bicarbonate (Samarin®) dissolved in water one hour before starting the stimulation with oxytocin


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date December 31, 2020
Est. primary completion date December 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- gestational age at least 37 + 0 weeks

- singleton pregnancy

- cephalic presentation

- active labor (regular painful contractions, effaced cervix open at least 3cm)

- arrested labour progress according partogram and clinic guidelines

Exclusion Criteria:

- intra uterine fetal growth retardation (> 22%)

- intra uterine fetal death

- threat of fetal asphyxia

- severe vaginal bleeding

- disproportion between the fetal head and the mother's pelvis

- hypertonic contractions (more than 5 in 10 minutes)

- known allergy or hypersensitivity to oxytocin or to any of derivatives

- women who cannot understand the information of the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Samarin
Arm: Active Comparator: B, Bicarbonate group When labour arrest is diagnosed and the first AFL > 12 mmol/L the participants will be randomized to two groups. In group B the participant will drink bicarbonate (2 packages of Samarin®) dissolved in 200 ml of water. Then after one hour the AFL will be measured again and the stimulation with oxytocin will be started if there is no progress in the cervix.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Turku University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Spontaneus Vaginal delivery by the end of the delivery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05533996 - Body Fat Index for Obstetric Risk Stratification N/A
Not yet recruiting NCT06249061 - Oral Sodium Bicarbonate for the Prevention of Labour Dystocia N/A
Active, not recruiting NCT02221427 - The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time Mothers N/A
Terminated NCT01397630 - Accelerated Titration of Oxytocin for Nulliparous Patients With Labour Dystocia: ACTION Pilot Study Phase 3